| Mrs Lisa Ann Walczak Thain, PHARMD | |
|
155 E University Dr, Granger, IN 46530-4474 | |
| (574) 243-9042 | |
| Not Available |
| Full Name | Mrs Lisa Ann Walczak Thain |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 155 E University Dr, Granger, Indiana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427335769 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 26021574A (Indiana) | Primary |
| 183500000X | Pharmacist | 13440-040 (Wisconsin) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Lisa Ann Walczak Thain, PHARMD 155 E University Dr, Granger, IN 46530-4474 Ph: (574) 243-9042 | Mrs Lisa Ann Walczak Thain, PHARMD 155 E University Dr, Granger, IN 46530-4474 Ph: (574) 243-9042 |
News Archive
The Ontario Long Term Care Association (OLTCA) appreciates that today's provincial budget contains measures to support long term care homes in maintaining care and service levels to over 76,000 of Ontario's oldest and frailest citizens. The association is also looking forward to the opportunity for continued discussions with government to attempt to resolve outstanding questions to further protect the capacity of homes to provide the care and services residents need.
Merck, a leading science and technology company, has introduced CAN MultiFlow™ screening services to more accurately predict genotoxic and mode of action* properties of substances, ingredients and drug compounds. Offered through its BioReliance® testing facilities, Merck will be the first company to provide this service in the United States.
FibroGen, today announced interim results of a phase 1/2 trial of FG-3019, a therapeutic antibody against connective tissue growth factor, in combination with gemcitabine and erlotinib in individuals with unresectable pancreatic cancer.
St. Jude Children's Research Hospital and the University of Florida Proton Therapy Institute have formed a collaboration to provide proton therapy for St. Jude patients. The announcement follows the approval of the first clinical study to evaluate the use of proton therapy for rare brain cancers in children younger than 3 years old.
Helsinn, the Swiss Group focused on building quality cancer care, announces today that its recently launched Helsinn Integrative Care division is meeting the cancer community at booth 6033 at the American Society of Clinical Oncology Annual Meeting, May 29-June 2, Chicago, Illinois.
› Verified 3 days ago
Mr. Philip Kline, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 13060 Adams Rd, Granger, IN 46530 Phone: 574-243-5468 Fax: 574-243-5664 | |
Adaora Ezenekwe, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15005 State Road 23, Granger, IN 46530 Phone: 574-271-2553 | |
Mary A Kertes, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 11716 Parke County Cir, Granger, IN 46530 Phone: 574-274-3640 Fax: 219-707-8123 | |
Dr. Michael Ross Futa, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15005 State Road 23, Granger, IN 46530 Phone: 574-271-2553 | |
Dr. Michelle Dies, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 155 E University Dr, Granger, IN 46530 Phone: 574-243-9042 | |
Anthony Carl Acito, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15005 State Road 23, Granger, IN 46530 Phone: 574-271-2553 | |
Christine Kwan, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15005 State Road 23, Granger, IN 46530 Phone: 574-271-2553 Fax: 574-271-2563 |